VW
GSK icon

Vantus Wealth’s GSK GSK Stock Holding History

Vantus Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
+3,819
New +$202K 0.11% 234
2025
Q4 		$252K Buy
+5,148
New +$240K 0.19% 168

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vantus Wealth's GSK Position: Q2 2026 in Review

Vantus Wealth opened a new position in GSK (GSK) in Q2 2026: 3,819 shares worth $200K. The stake represents 0.11% of the portfolio and ranks #234 among its holdings. This is a return to the name: Vantus Wealth previously reported a position in GSK as recently as Q4 2025.

Vantus Wealth first reported a position in GSK in Q4 2025 and has held it in 2 quarters since. The position peaked at $252K in Q4 2025. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Vantus Wealth held 3,819 shares of GSK worth $200K as of Q2 2026.
  • GSK was a new Vantus Wealth position in Q2 2026.
  • GSK made up 0.11% of Vantus Wealth's portfolio in Q2 2026, its #234 holding.
  • Vantus Wealth first reported a position in GSK in Q4 2025 and has held it in 2 quarters since.
  • Vantus Wealth's GSK position peaked at $252K in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Vantus Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.